On the afternoon of January 25th, Ruistan Biology and the People's Government of Yubei District of Chongqing jointly built the unveiling activities of "Biomedical R&D Center", "Biomedical Clinical Transformation Center", "Regional Cell Preparation Center" and "Regional Comprehensive Cell Bank", which were held by xiantao Data Valley Conference Center. The ceremony was attended by relevant leaders of the Yubei District Development and Reform Commission, the District Medical Insurance Bureau, the District Food and Drug Administration, the relevant responsible persons of the Yubei Maternal and Child Health Hospital, and the relevant responsible persons of Xiantao Data Valley and Xiantao Street. This meeting marked that Yubei District will make a big leap into the fast lane of the biotechnology industry, drive the rapid improvement of the level of medical and health care systems in the field of biomedicine and health technology in the region, and promote the landing of the three major plans of Ruistan "Kangmin Xingbang" in Yubei District, benefiting the people in the district and radiating to the entire Chongqing Municipality and southwest China.
The unveiling activity was presided over by Mr. Cheng Huiping of Xiantao Data Valley, and Cong Hao, general manager of Ruistan Cell Bank, first introduced the original intention of Ruistan Biology and Yubei District Government to build four centers, and after multi-party long-term investigation and preparation, with the strong support of the district government, the four centers and a number of advanced biotechnology projects were landed in Yubei District. In this way, we will jointly build a scientific research and application platform, clinical transformation and technical service platform, municipal biotechnology and cell application demonstration base and industrial highland in the biomedical field in Yubei District. Promote the promotion and use of emerging biomedical technologies in the hospital system in the region, improve the level of medical technology, and reach the international leading level.
Subsequently, Teng Miao, executive vice president of Yubei District People's Hospital, introduced the cooperation project between Ruistan and District People's Hospital in biomedical research and clinical translation. Comprehensively carry out research on the clinical application of SVF treatment technology and NK cell immunotherapy in medical treatment, and jointly promote the storage of newborn umbilical cord stem cells in the region. The "Kangmin Xingbang" beneficial plan launched by Ruistan in Yubei District includes: an "NK immunization program" to improve the people's disease prevention and anti-cancer health index with NK immune cell technology, which greatly reduces cancer incidence and mortality; the second "cell storage plan" greatly improves the national cell storage rate; the third "SVF plan", with SVF (vascular matrix component) technology to greatly reduce the disability rate of spinal cord injury, osteoarthritis, pediatric cerebral palsy, stroke, Alzheimer's disease, Parkinson's disease and other diseases, and improve the quality of life. With new biomedical technology to escort the health of the people in Yubei District! The implementation of the "three plans" is provided by the hospital to provide medical services such as testing, collection, and clinical application.
Jiao Yang, chairman of Rustan Biology, told everyone about the scientific research development and application path of cell technology, so that everyone clearly understood that cell medical technology has been able to solve many difficult and serious diseases that traditional therapy cannot solve, such as cell technology has helped high paraplegic patients with spinal cord injury to stand up and walk again, help patients with degenerative and sports injury joints eliminate pain, repair joint function, help stroke patients solve sequelae, and so on. Ristam has also launched a scientific research project on in vitro tissue engineering to help organ transplant patients solve the global challenges of donor scarcity and rejection in the future. These biotechnology achievements can build firm confidence in medical institutions and let people see the hope of life and health. Ruistan launched the "Kangmin Xingbang" plan to benefit the people, landed in Chongqing Yubei District, with the support of the district government and the Health Commission, launched the NK immune cells and stem cells of the general Save storage plan, immunity testing, cancer early screening, cardiovascular and cerebrovascular disease risk detection and other excellent inspection programs to the people of Yubei District, providing a real and useful life and health protection for the people and the whole family.
In the post-epidemic era, epidemic prevention and control has become the new normal, improving people's health awareness, enhancing their own immunity, responding to the invasion of viruses and malignant tumors, and becoming the first priority to stabilize society, protect people's lives and health, and ensure the resumption of normal production and life. Ma Chengquan, deputy mayor of Yubei District of Chongqing Municipality, affirmed the "four centers and three plans" jointly built this time, and in addition to the practical and social significance, the plan for the benefit of the people is also an important opportunity to use advanced biotechnology to provide long-term protection for the lives and health of the people in Yubei District. In addition to enabling the people in the region to take the lead in enjoying the cell technology dividend before the people of the whole country, but also to enable the people in the region to avoid returning to poverty due to illness, it also plays an important role in improving the level of cell medicine in Yubei District, and even In Chongqing City and the entire southwest region, it is conducive to the long-term deployment of the great health strategy of the contemporary gong in the future. At the same time, it instructs the Health commission, science and technology bureau, medical insurance bureau and other units in the district to vigorously support such enterprises that really do good deeds, do practical things, have feelings, responsibilities and strength, and work together to revitalize the industry, serve the society and the people.
After the speech, the official unveiling was held, Ma Chengquan, deputy governor of Yubei District Government, Hu Rong, vice chairman of the Yubei District CPPCC Committee, secretary of the Party Committee and director of the District Health Commission, Jiao Yang, chairman of Ruistan Biology, Wu Wutian, chief technical director of Ruistan, Cong Hao, general manager of Ruistan Cell Bank, Zhong Huabin, regional manager of Ruistan Chongqing, Teng Miao, executive vice president of Yubei People's Hospital, and leaders of the Science and Technology Bureau took the stage to unveil the "four centers". After the ceremony, under the leadership of Cong Hao, the guests visited the "Regional Cell Preparation Center" and "Regional Comprehensive Cell Bank" located in Xiantao Data Valley.
During the interview, the reporter learned that Ruistan Biology will also cooperate with the Yubei District Maternal and Child Health Hospital and other hospitals in the region to launch the umbilical cord mesenchymal stem cell universal Save storage plan for the pregnant families of newborn babies in Yubei District, and carry out the first batch of pilots in Yubei District: Where maternal families produced in hospitals in Chongqing, choose TheRastan Storage Umbilical Cord Mesenchymal Stem Cell Project can enjoy a preferential policy of less than 20,000 yuan for storage for 20 years (the current market price is: 25,000-35,000 yuan) If either parent of a newborn belongs to the household registration of Yubei District, or gives birth in a hospital in Yubei District, and chooses TheRastan Storage Umbilical Cord Mesenchymal Stem Cell Service, you can enjoy the preferential policy of less than 10,000 yuan storage for 20 years. Ruistan Bio cooperated with Yubei District People's Hospital to carry out research on the clinical and medical applications of SVF and immunotherapy projects, and launched the general Save storage plan of fat mesenchymal stem cells, NK immune cells, clinical treatment recruitment plan, and early detection of various diseases to benefit the people of Yubei District.
Ruistan Biology has always adhered to the ESG concept, in addition to carrying out the three major plans of "Kangmin Xingbang", it also launched the "Ruistan Lonely Boat Baby Rescue and Treatment Plan" to treat poor children with cerebral palsy with SVF technology. In 2020, the immunotherapy project of Ruistan Biology and Gannan Medical College was approved, and the cancer immunotherapy project cooperated with Shanghai Ruijin Hospital in 2021 was approved, and NK immune cells have unlimited prospects in antiviral and anti-tumor. Ruistan's SVF treatment technology has made certain breakthroughs in the treatment of osteoarthritis, spinal cord injury repair, stroke, Alzheimer's disease and other diseases, and has carried out SVF treatment of stroke project with Beijing Tiantan Hospital and Shenyang Northern Theater General Hospital, SVF treatment of pediatric cerebral palsy project with the Third hospital and second hospital of Ganyi University, and in addition, SVF clinical project for the treatment of spinal cord injury in Hospitals in Kunming... At a conference at the Shanghai Expo in 2021, Jiao Yang officially released Ruistan's innovative research project on EVOF in vitro tissue engineering, with the goal of breaking through the global problems in the field of human organ transplantation in 5-10 years. It can be seen that in the future, there will be more difficult and serious diseases that cannot be cured by traditional therapies now, which are expected to be cured by new cell technology.
Upstream journalist Gu Li